News
Novavax posts encouraging first-quarter results on the back of an additional $603 million in revenues recognized from the ...
Novavax Inc (NVAX) reports a dramatic revenue increase and strategic collaborations, while navigating regulatory hurdles and ...
Wall Street’s major averages ended the week slightly lower on Friday, losing gains for the week amid renewed optimism about ...
Novavax Inc. closed 74.96% below its 52-week high of $23.86, which the company reached on June 6th.
Novavax (NASDAQ:NVAX) shares climbed ~35% in the premarket on Thursday after the COVID-19 vaccine maker lifted its full-year ...
QBTS: D-Wave Quantum shares are rallying after the company beat analysts' estimates and reported record quarterly revenue ...
Novavax (NVAX) smashed its Q1 2025 earnings today. The stock rocketed 33% in pre-market trading after the company reported a stunning $518 million profit for Q1 2025. This marks a complete turnaround ...
Analysts are estimating that Novavax will report an earnings per share (EPS) of $0.19. The market awaits Novavax's ...
Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...
Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsLuis Sanay - Vice President, Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results